1. Localizedin vivo13C NMR spectroscopy of the brain
2. , , , In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism. NMR Biomed. 2003; 16: 339–357.
3. Cerebral glucose metabolism and the glutamine cycle as detected by in vivo and in vitro 13C NMR spectroscopy
4. Criteria for significant risk investigations of magnetic resonance diagnostic devices—guidance for industry and FDA staff. FDA, Center for Devices and Radiological Health, 2003.
5. Medical electrical equipment: particular requirements for the safety of magnetic resonance equipment for medical diagnosis. IEC 2002; 601–2–23.